Skip to main content
. Author manuscript; available in PMC: 2017 Aug 23.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2009 Jul 15;50(12):5577–5586. doi: 10.1167/iovs.08-1857

Table 1.

Summary of All-trans Retinol Binding to X21RBP and Its Tryptophan to Phenylalanine Substitution Mutants

Protein Sites (N)
Kd (μM)
Enhancement Quenching Energy Transfer
X2IRBP N 1.27 ± 0.03 1.26 ± 0.02 1.26 ± 0.02
Kd 0.07 ± 0.02 0.008 ± 0.003 0.033 ± 0.008
W450F N 0.62 ± 0.09 0.83 ± 0.08
0.72 ± 0.06* ND
Kd 0.45 ± 0.11 0.29 ± 0.08
0.48 ± 0.05* ND
W587F N 1.07 ± 0.01 0.97 ± 0.02 1.20 ± 0.01
1.40 ± 0.04* 1.31 ± 0.03* ND
Kd 0.07 ± 0.01 0.05 ± 0.01 0.10 ± 0.01
0.05 ± 0.04* 0.06 ± 0.01* ND

Calculated parameters were derived from titrations illustrated in Figure 4, except for those indicated by *, which correspond to titrations in Figure 5 where the protein used came from a separate expression and purification. ND, not done.

Not calculated, insufficient quenching.